HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.

Abstract
The rare recurrent translocation of (8;9)(p22;p24) with PCM1-JAK2 fusion was recently characterized in diverse hematological malignancies. Most of them are atypical chronic myeloid leukemia (CML) or other myeloproliferative disorders (MPD), and are predominantly in the male. We report a female patient with acute myeloid leukemia (AML) initially presenting with normal karyotype and negative HLA-DR expression who achieved complete remission after standard chemotherapy. The disease relapsed 7 months later with cytogenetic change of t(8;9)(p22;p24). Flow cytometry analysis showed evolutional change of immunophenotype from negative to positive HLA-DR expression and fluorescence in situ hybridization (FISH) analysis demonstrated a PCM1-JAK2 fusion gene. We speculate that the cytogenetic change of t(8;9)(p22;p24) may induce HLA-DR immunophenotypic switch and a coordination of the two evolutional changes may play a role in leukemic cell progression.
AuthorsKuan-Po Huang, Andrew J Chase, Nicholas C P Cross, Andrea Reiter, Tzu-Ying Li, Tso-Fu Wang, Sung-Chao Chu, Xuan-Yin Lu, Chi-Cheng Li, Ruey-Ho Kao
JournalInternational journal of hematology (Int J Hematol) Vol. 88 Issue 2 Pg. 197-201 (Sep 2008) ISSN: 0925-5710 [Print] Japan
PMID18594780 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantigens
  • Cell Cycle Proteins
  • HLA-DR Antigens
  • Oncogene Proteins, Fusion
  • PCM1 protein, human
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Autoantigens (genetics)
  • Cell Cycle Proteins (genetics)
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 8
  • Chromosomes, Human, Pair 9
  • Fatal Outcome
  • Female
  • Flow Cytometry
  • Gene Expression Regulation, Leukemic
  • HLA-DR Antigens (genetics)
  • Humans
  • Immunophenotyping
  • Janus Kinase 2 (genetics)
  • Leukemia, Myeloid, Acute (genetics, pathology)
  • Middle Aged
  • Oncogene Proteins, Fusion (genetics)
  • Recurrence
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: